
Apellis Pharma (APLS) Earnings Dates & Reports
Apellis Pharma (APLS) Most Recent Earnings
Report DateJul 31, 2025
Period EndingQ2 2025
Est. EPS-$0.46
Actual EPS-$0.33
EarningsBeat
Apellis Pharma (APLS) Earnings
View the latest Apellis Pharma (APLS) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Apellis Pharma (APLS)
Order type
Buy in
Order amount
Est. shares
0 shares
Apellis Pharma (APLS) Earnings per Share (EPS) History
Signup for full accessBrowse free
Apellis Pharma (APLS) Latest Earnings
The value each APLS share was expected to gain vs. the value each share gained.
Apellis Pharma (APLS) reported its most recent earnings on Jul 31, 2025 for Q2 2025, posting earnings per share (EPS) of -$0.33. This exceeded analysts' expectations of -$0.46 by 28.26%, marking a Beat.
For comparison, Apellis Pharma reported EPS of -$0.28 in the same quarter last year.
The company is expected to announce its next earnings report on 11/04/2025, with analysts projecting an EPS of $0.14.
Apellis Pharma (APLS) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q3 2025Nov 4, 2025 | $0.14 | Next earnings call Nov. 4, 2025 | ||
Q2 2025Jul 31, 2025 | -$0.46 | -$0.33 | -28.26% | |
Q1 2025May 7, 2025 | -$0.34 | -$0.74 | +117.65% | |
Q4 2024Feb 28, 2025 | -$0.40 | -$0.29 | -27.50% | |
Q3 2024Nov 5, 2024 | -$0.30 | -$0.46 | +53.33% | |
Apellis Pharma (APLS) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Apellis Pharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Jul 31, 2025 | — | — | — |
May 7, 2025 | — | — | — |
Feb 28, 2025 | — | — | — |
Nov 5, 2024 | — | — | — |
Apellis Pharma (APLS) Earnings FAQs
Apellis Pharma (APLS) last reported earnings on Jul 31, 2025 for Q2 2025, posting an EPS of -$0.33, which Beat the estimate of -$0.46 by 28.26%.
For Q2 2025, Apellis Pharma (APLS) reported an EPS of -$0.33, exceeding analysts' estimate of -$0.46 by 28.26%.
For Q2 2025, Apellis Pharma (APLS) Beat expectations with an actual EPS of -$0.33 vs. an estimated EPS of -$0.46.
Following the last earnings report on Jul 31, 2025, Apellis Pharma (APLS)'s stock price moved — from — to —.
The next Apellis Pharma (APLS) earnings call is scheduled for Nov. 4, 2025, where executives will discuss financial results and outlook.